The Development and Evaluation of Next-Generation Smallpox Vaccines
Meeting on September 16, 2011, from 8 a.m. to 5:30 p.m.
The public workshop will: (1) Discuss regulatory challenges and approaches related to the licensure of next generation smallpox vaccines; (2) discuss the strengths and weaknesses of various animal models relative to their ability to mimic human disease that can be used to predict the effectiveness of humans; (3) discuss the most appropriate methods to bridge immunogenicity of next-generation smallpox vaccines to licensed smallpox vaccines in clinical trials; and (4) discuss viable methods of extrapolating clinical efficacy of next-generation smallpox vaccines from immunogenicity and efficacy data from relevant animal models.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment